Catalyst Wire Dossier Catalyst Wire Dossier

Maplirpacept

PF-07901801 · Pfizer
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Maplirpacept, covering 2024-09-03 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma [Phase 1]

See pricing